In vitro and in vivo antibacterial activities of BMY 40062, a new fluoronaphthyridone.

The in vitro and in vivo activities of a new naphthyridone, BMY 40062, were compared with those of ciprofloxacin and ofloxacin. BMY 40062 showed about threefold more activity than ciprofloxacin showed and four- to eightfold more activity than ofloxacin showed against staphylococci, streptococci, and...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Fung-Tomc, J, Desiderio, J V, Tsai, Y H, Warr, G, Kessler, R E
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1989
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC284253/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2764541/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.33.6.906
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!